baber/WOPTO huggingface dataset:
Patent NZ-334640-A (NZ)
Title: Tap with plastics components and locking collar which locks the spindle
Inventor: EAGLE JOHN JOSEPH
IPC: E03C1/04
Filed: 1997-09-19
Abstract: A tap body includes a plastic shroud 6, a plastic tap spindle 7 and locking collar 12.  The body has an inner insert 5 which has an internal threaded portion 18.  Spindle 7 has an external threaded portion 19 which engages threaded portion 18 to reciprocate spindle 7 when it is rotated.  Locking collar 12 prevents spindle 7 from being detached from shroud 6 as spindle 7 is rotated to open the tap.  Insert 5 may be metal or may be integral with plastics shroud 6.
Patent NZ-336849-A (NZ)
Title: Stacking and nesting containers
Inventor: TOWNSON DAVID JOHN
IPC: B65D21/04
Filed: 1998-01-20
Abstract: The specification describes a container (110) and a stacking bars (112) which can, either be stowed in the floor of the container, or raised to allow stacking at an intermediate height.  Hooks (152) are formed integrally with the stacking bars.  When a container is nested into a container below it the hooks of the container can be released by the nesting action.  This allows the stacking bars to hinge down to their stowed position.
Patent NZ-337154-A (NZ)
Title: Harvester with drawbar having horizontal and vertical axis pivots, and rear steerable wheels, to enhance travelling motion of harvester
Inventor: SLACK MARK
IPC: A01D17/00
Filed: 1999-05-12
Abstract: he harvester has front drawbar apparatus as per the Applicant's co-pending patent 335718.  It also has rear steerable wheels 10, 11 controllable so that the harvester can travel in a straight path when the towing tractor is turning at a headland.
Patent NZ-505282-A (NZ)
Title: Gene encoding a zif amino acid sequence: a bacteriolytic enzyme (zoocin A) immunity factor capable of protecting a host cell expressing zoocin A against its potentially damaging activity
Inventor: SIMMONDS ROBIN STUART
IPC: A23L1/00
Filed: 1998-11-23
Abstract: A factor, which has activity in protecting a cell against the bacteriolytic enzyme, zoocin A, is described.  The nucleic acid encoding the factor is useful in transforming GRAS (generally regarded as safe) organisms to be able to produce zoocin A without vulnerability to the activity of the enzyme itself.  The resulting organisms can then be used in antibacterial compositions  - particularly foodstuffs - against a range of bacteria, including Staphylococcus mutans, S. sobrinus and S. pyogenes.
Patent NZ-508533-A (NZ)
Title: Cosmetic preparation of active substances with high protection factor against free radicals containing Quebracho blanco and silkworm extracts
Inventor: GOLZ-BERNER KARIN
IPC: A61K8/00
Filed: 1999-06-22
Abstract: Cosmetic active substance preparation with a radical protection factor comprises: a) 0.1 to 10 wt. % of a product obtained by extraction of the bark of Quebracho blanco and subsequent enzymatic hydrolysis, containing at least 90 percent by weight of proanthocyanidine oligomers and up to 10 percent by weight of gallic acid and present as a microcapsule with a concentration of the extraction product of 2 wt %; (b) from 0.1 to 10 wt. % of an extract of silkworm obtained by extraction, containing the peptide cecropine, amino acids and a vitamin mix; (c) 0.1 to 5 wt. % of a non-ionic, cationic or anionic hydrogel or mixture of hydrogels; (d) 0.1 up to 30 wt. % of at least one phospholipid and (e) water. The radical protection factor is in the range 100 to 3500 X 1014 radicals/ mg preparation.
Patent NZ-508672-A (NZ)
Title: Release sheet for use with multicomponent reactive urethane systems and method of manufacture
Inventor: GLASSOCK JUDITH I
IPC: B29C59/00
Filed: 1999-06-02
Abstract: A flexible composite release sheet 10 for use in multicomponent reactive urethane casting systems providing a replicative surface with a desired surface effect. (e.g texture, 3D relief patterns, highly glossy mirror finishes, etc). The flexible composite release sheets have a substrate 11, a first acrylic functional coating layer 12 containing the desired surface effect to be replicated and a second silicone release coating layer 13 overlying the acrylic functional coating layer for providing acceptable release of a cast film of the curable material.
Patent NZ-508693-A (NZ)
Title: Process for producing formyl imidazoles
Inventor: BESSARD YVES
IPC: C07D233/64
Filed: 1999-06-11
Abstract: A procedure for the catalytic conversion of hydroxy methyl imidazoles to formyl imidazoles of formula I. The catalysis takes place in the presence of a peroxide. Formyl imidazoles are important intermediate products for pharmaceutical substances
Patent NZ-512161-A (NZ)
Title: (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
Inventor: BURKE JAMES A
IPC: A61K31/495
Filed: 1999-12-28
Abstract: A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having formula (I), and pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R1 and R2 each is selected from the group consisting of alkyl radicals containing 1 to 4 carbon atoms and alkoxy radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R3, R4 and R5 each is located in one of the remaining 5- , 6-, 7- or 8- positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide reduction in chronic peripheral pain.
Patent NZ-513486-A (NZ)
Title: Communication cabling system for providing and controlling coupled power sent with data signals
Inventor: LEHR AMIR
IPC: H04L29/08
Filed: 1999-12-19
Abstract: A local area network including a hub (10), a plurality of nodes (12, 14, 16, 18, 20, 22), communication cabling (11) connecting the plurality of nodes to the hub for providing data communication, and a power supply distributor (30) operative to provide at least some operating power to at least some of the plurality of nodes via the communication cabling.
Patent NZ-514690-A (NZ)
Title: Modulation of excitable tissue function by peripherally administered erythropoietin
Inventor: BRINES MICHAEL
IPC: A61P25/28
Filed: 2000-04-13
Abstract: EPO, an EPO receptor activity modulator or an EPO-activated receptor modulator is used for preparing a pharmaceutical composition for the protection of a mammal from pathology resulting from injury to excitable tissue wherein the pharmaceutical composition is adapted of peripheral administration of an effective non-toxic amount of the composition for the protection for an excitable tissue in an amount and dosage regime sufficient or achieve the protective effecting, with the proviso that the injury is not a result of cerebral ischemia. Preferably the injury is a result of seizure disorder, multiple sclerosis, hypotension, cardiac arrest, retinal ischemia, heart ischemia, myocardial infarction, inflammation, age-related loss of cognitive function, radiation damage, cerebral palsy, neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Leigh disease, AIDS, dementia, memory loss, amyotrophic lateral sclerosis, alcoholism, mood disorder, anxiety disorder, attention deficit disorder, autism, Creutzfeld-Jakob disease, brain or spinal cord trauma, heart-lung bypass, glaucoma, retinal trauma or hypoxia. EPO, an EPO receptor activity modulator or an EPO-activated receptor modulator cab also be used for preparing a pharmaceutical composition for enhancing the function of normal or abnormal excitable tissue. Preferably enhancing the function results in the enhancement of associative learning or memory.
Patent NZ-515359-A (NZ)
Title: Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
Inventor: TICE THOMAS R
IPC: A61K47/34
Filed: 2000-04-08
Abstract: A microsphere composition comprising; naltrexone free base in an amount in the range of 15 to 50 weight %; poly (D, L-lactide) as a matrix; less than about 3 weight % ethyl acetate, capable of providing a physiological effective level of naltrexone to reduce the consumption of heroin and alcohol when administered intramuscularly in a mammal over a period of 28 days; and at least 90 weight % of said microsphere composition comprising microspheres having a diameter in the range of 20 to 100 ìm.
Patent NZ-516332-A (NZ)
Title: Remote parturition alarm
Inventor: HARADA MASAHIDE
IPC: H04L29/08
Filed: 2001-04-23
Abstract: A parturition managing system advantageously solving the problem of a conventional monitoring system for monitoring a domestic animal the delivery of which is approaching. The monitoring work by a monitor of the domestic animal such as a veterinary is lightened and the cost and labour of the keeper of the domestic animal such as a stock farmer are reduced. The system comprises one or more types of domestic animal biological data measuring means (1) for measuring the variation of the delivery condition of a domestic animal and outputting the result as measurement data, data relaying means (2) for outputting the measurement data from the domestic animal biological data measuring means on a communication line (L), data display means (3) for receiving the measurement data sent through the communication line (L) and displaying it, and reporting means (4) for reporting, if the domestic animal judged to exhibit a sign of delivery or to be delivering on the basis of the displayed measurement data, delivery information to the keeper of the domestic animal.
Patent NZ-518736-A (NZ)
Title: N6 heterocyclic 8-modified adenosine derivatives
Inventor: ZABLOCKI JEFF A
IPC: A61P25/28
Filed: 2000-11-29
Abstract: Compounds of formula (I) are disclosed, for which the variables are defined herein. The compounds are used in the manufacture of medicaments for use as adenosine receptor agonists, for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders.
Patent NZ-520043-A (NZ)
Title: Vehicle roof rack
Inventor: HUBBARD PETER DOUGLAS
IPC: B60R9/048
Filed: 2002-08-09
Abstract: A vehicle roof rack includes a pair of foot assemblies (2) fixed to an elongate roof rack bar (1) and adapted to be secured to opposing sides of the roof of the vehicle. Telescoping members are received within the roof rack bar for telescoping movement with respect to both foot assemblies for extending the overall load-carrying length of the roof rack. The telescoping member extends from an aperture in the foot assembly and has an end section (5, 6) that, when the telescoping member is retracted, neatly closes the aperture and blends smoothly with the adjacent outer surface of the foot assembly.
Patent NZ-521949-A (NZ)
Title: A two-terminal power switch with line-powered switch controller
Inventor: LO CHUNG PING KEVIN
IPC: H01H47/22
Filed: 2002-10-11
Abstract: An electrical power switch consisting of a two-terminal switch with a line-powered switching controlled mechanism. First and second shunt circuits are provided between the terminals of the power outlet with the first shunt circuit containing a power supply operating from current flowing through the switch when in the "ON" condition. This power supply can power a means to control the operative state of the switch while current flows through. When the switch is in the "OFF" state, a second power supply contained in the second shunt circuit provides power to the control means.
Patent NZ-523445-A (NZ)
Title: Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
Inventor: WANG GARY T
IPC: C07D401/14
Filed: 2001-06-22
Abstract: Heterocycyl-containing diaryl sulfide compounds of formula (I) useful for treating inflammatory and immune diseases, pharmaceutical compositions comprising such compounds and the use of such compounds in the preparation of a medicament for inhibiting inflammation or suppressing immune response in a mammal in need thereof.
Patent NZ-523570-A (NZ)
Title: Detectable heavy duty needle where the needle cannula comprises a magnetized stainless steel alloy for detection in metal detectors
Inventor: PRINDLE GORDON E
IPC: G01V3/08
Filed: 2001-07-27
Abstract: A detectable heavy duty needle cannula (12) is disclosed for use in hypodermic syringes and the like. Needle cannula (12) comprises a magnetizable or magnetized stainless steel alloy, which enables needle cannula (12) to be detectable in metal detectors that are commonly used in the meat processing industry to detect broken needle cannulas in the flesh of slaughtered animals. Needle cannula (12) further comprises a sidewall (17) that is thicker than the sidewalls of prior art needle cannulas. The thicker sidewall imparts to needle cannula (12) greater resistance to breakage during the process of injecting animal health products into an animal and greater detectability in a metal detector.
Patent NZ-528052-A (NZ)
Title: Wood cutting apparatus with discs each having teeth defining distinct cutting diameters
Inventor: STAGER BRADLEY R
IPC: B27C5/00
Filed: 2003-09-05
Abstract: In order to make facing cuts on timber the apparatus has axially spaced disk-saws with respective cutting teeth for producing respective slicing cuts.
Patent NZ-530109-A (NZ)
Title: Prodrugs of GABA analogs, compositions and uses thereof
Inventor: GALLOP MARK A
IPC: C07C261/00
Filed: 2002-06-11
Abstract: Disclosed herein are compounds of formula (I), formula (II) and formula (III), prodrugs of GABA analogs thereof, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs, wherein the variables shown in these formulae are as defined in the specification. Also described are methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.
Patent NZ-534086-A (NZ)
Title: Use of an aldosterone synthase inhibitor in combination with an angiotensin I receptor antagonist or an angiotensin I receptor antagonist plus a diuretic to treat various conditions
Inventor: STEELE RONALD EDWARD
Filed: 2001-04-10
Abstract: Described is the use of a pharmaceutical composition comprising the aldosterone synthase inhibitor fadrozole or a pharmaceutically acceptable salt thereof alone, for the manufacture of a medicament for the prevention of, delay of progression of, treatment of a disease or condition selected from the group including any one of; (a) congestive heart failure, renal failure, chronic renal failure, restenosis after percutaneous transluminal angioplasty, and restenosis after coronary artery bypass surgery; (b) atherosclerosis, insulin resistance and syndrome X, diabetes mellitus type 2, nephropathy, renal failure, chronic renal failure, hypothyroidism, survival post myocardial infarction (Ml coronary heart diseases, increase of formation of collagen, and remodelling following hypertension; and (c) endothelial dysfunction. The use as described wherein the aldosterone synthase inhibitor is the (+) enantiomer of fadrozole or a pharmaceutically acceptable salt thereof of formula
Patent NZ-535854-A (NZ)
Title: Drug microparticles
Inventor: LERNER ITZHAK E
IPC: A61K9/16
Filed: 2003-03-25
Abstract: Disclosed herein is a drug delivery vehicle that comprises a pharmaceutical carrier particle bearing microparticles of a drug deposited on the pharmaceutical carrier particle from a solid solution of the drug in a sublimable carrier, and methods of making said drug delivery vehicle.
Patent NZ-538098-A (NZ)
Title: Lytic phage P100 ATCC deposit designation PTA-4383 to control listeria monocytogenes in foodstuffs and in food processing plants and treat animals infected
Inventor: LOESSNER MARTIN
IPC: A01N63/00
Filed: 2003-07-07
Abstract: A method for controlling Listeria contamination in a food product, on processing equipment or on food storage containers, comprises applying lytic phage P100, ATCC deposit number PTA-4383, to a food product or food processing equipment in an amount sufficient to reduce the amount of Listeria. Also described is the use of P100, ATCC deposit number PTA-4383 to prepare a composition suitable to reduce or eliminate Listeria monocytogenes in an animal infected with Listeria monocytogenes, methods for detecting the presence of Listeria monocytogenes, and a purified endolysin protein derived from phage P100, ATCC deposit number PTA-4383.
Patent NZ-539704-A (NZ)
Title: Electric curtain gate
Inventor: ALDER COLIN RICHARD
Filed: 2005-04-29
Abstract: An electric curtain gate or barrier, made from a plurality of spaced apart stiff flexible elongate rods, having a fibreglass core and an electrically conducting braided outer layer is disclosed. The plurality of spaced apart elongate rods are adapted to extend across an entrance way and are adapted to conduct electricity to deter the passage through the gate or barrier. The electric curtain gate provided is also adapted to deflect away from the entrance way when a moving source passes through the gate or barrier and to return across the entrance way once the moving source has passed through the entrance way.
Patent NZ-542444-A (NZ)
Title: Valved male luer
Inventor: DOYLE MARK C
IPC: A61M39/04
Filed: 2004-02-20
Abstract: A male luer includes a tubular conduit 118, 124 and a resilient member 106 positioned over the tubular member and extending coaxially therewith. A valve member 116 at the forward end of the resilient member openably seals the forward end of the tubular member. When the male luer 100 is inserted into the female luer 128, the female luer contacts the resilient member at projecting tabs 108 to drive the resilient member into a compressed position and to open the valve and permit flow of liquid from one luer to the other through the tubular conduit of the male luer.
Patent NZ-543574-A (NZ)
Title: Rotor blade of a wind energy facility
Inventor: WOBBEN ALOYS
IPC: F03D1/06
Filed: 2004-03-29
Abstract: A wind energy facility and to a wind energy facility. The rotor blade is provided with a blade profile which has an improved efficiency. The rotor blade has a position of maximum thickness of approximately 15 % to 40 % of the rotor blade length, preferably from approximately 23 % to 28 %; the maximum profile thickness lying between 20 % to 45 % of the cord length of the rotor blade, preferably from about 32 % to 36 %. The rotor blade has a two part configuration in the root area; a part of a rotor blade is configured in the outer side of the hub lining; the ratio between the profile depth of a rotor blade and the diameter of the rotor is approximately from 0.04 to 0.1 and the ratio between the depth of the profile of a rotor blade and the diameter of the spinner is between 0.5 and 1.
Patent NZ-543824-A (NZ)
Title: Micro Organism Testing Device
Inventor: SHARPIN ROSEMARY KATHERINE CAMERON
Filed: 2005-11-29
Abstract: A micro-organism testing device is disclosed. The device 1 comprises a resealable container 2, 4, 11 under reduced pressure containing a growth medium and a cap 3 to capture the resealable portion of the container. The cap is provided with internal means adapted to puncture the resealable portion of the container. The cap is moveable between a first and a scond position wherein travel of the cap between the first and second positions will cause the internal means to puncture the resealable portion of the container.
Patent NZ-545095-A (NZ)
Title: Improved mixing methods and associated mixing units
Inventor: COSGROVE KEVIN
Filed: 2003-11-07
Abstract: A method for bulk mixing a dry particulate material and a liquid to form an aqueous solution includes the steps of (a) adding dry particulate material to a liquid in a mixing tank holding at least 50 litres of liquid at a flow rate of 9kg/min or less, and (b) pumping aqueous solution in the tank in a recycle loop from the base of the tank to the top of the tank at a flow rate sufficient to create a turbulent environment in the tank liquid.
Patent NZ-545181-A (NZ)
Title: Nonsedating A-2 agonist 1-(2,3-dimethyl-phenyl)-ethyl-,3-dihydro-imizadole-2-thione
Inventor: CHOW KEN
IPC: C07D233/84
Filed: 2004-08-20
Abstract: Disclosed is an alpha-2A/alpha-1A selective agonist, comprising a compound represented by formula I or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof.
Patent NZ-545208-A (NZ)
Title: A hub locking device for a disc-shaped recording media
Inventor: KOTZE ANTON EWALD
Filed: 2004-08-26
Abstract: A hub locking device (200) comprising a protrusion (230), a clamping disc (220) and a locking button. The protrusion is preferably located on a wall of a digital media storage case (100) and comprises a recess and at least one first mating portion (232). The clamping disc has a central aperture (231) and a plurality of resilient arms (223) extending downwardly from the central aperture. The resilient arms are receivable within the recess of the protrusion and each arm has a second mating portion (224) located thereon. The locking button (210) is locatable with the central aperture of the clamping disc. The hub locking device (200) is locked when the locking button (210) holds the at least one first mating portion (232)in engagement with each second mating portion.
Patent NZ-552978-A (NZ)
Title: Method and apparatus for drilling and servicing subterranean wells with rotating coiled tubing
Inventor: BORST TERENCE
IPC: E21B19/22
Filed: 2005-07-01
Abstract: A system is provided for drilling and/or servicing a well bore using continuous lengths of coiled tubing (14) in which a turntable assembly (18) rotates a coiled tubing reel (28) assembly and a counter balance system (26) about the well bore such that the coiled tubing is rotated while in the wellbore. A coiled tubing injector (22) may be provided on a separate turntable assembly or on the same turntable assembly as the reel assembly.
Patent NZ-556746-A (NZ)
Title: Device for cement augmentation of bone implants utilizing hollow cylinders
Inventor: FRIGG ROBERT
IPC: A61B17/86
Filed: 2005-03-24
Abstract: A device 10 for the cement augmentation of bone transplants that includes a hollow cylinder 1 that has a front end 3 suitable for insertion into a bone 20 with perforations in the front half of the cylinder. A screw 7 is inserted into the rear of the hollow cylinder 1 to force bone cement from the inside of the cylinder through the perforations 6 into the bone matrix.
Patent NZ-562351-A (NZ)
Title: Method and composition for treating mucosal disorders using a prostaglandin such as lubiprostone
Inventor: UENO RYUJI
IPC: A61K31/557
Filed: 2006-03-22
Abstract: Disclosed is the use of a prostaglandin compound of formula (II), wherein the substituents are as defined in the specification, provided that one of X1 and X2 is halogen or Z is C=O, in the manufacture of a medicament for the treatment of inflammatory bowel disease (IBD).
Patent NZ-566796-A (NZ)
Title: Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
Inventor: LULLA AMAR
IPC: A61K31/551
Filed: 2006-08-31
Abstract: Disclosed is a pharmaceutical composition comprising a single dosage unit containing lamivudine, stavudine, and nevirapine, or pharmaceutically acceptable salts or esters thereof, comprising 10-120 mg lamivudine, 1-30 mg stavudine and 25-170 mg nevirapine, wherein said stavudine is separated from said nevirapine and lamivudine within the composition. Also disclosed is the use of said composition in the treatment of viral infections and a method of preparing said compositions.
Patent NZ-574432-A (NZ)
Title: Preparation of fatty acid esters of glycerol formal and its use as biofuel
Inventor: ESTEVEZ COMPANY CARLES
IPC: C07D317/26
Filed: 2007-07-11
Abstract: Disclosed is the use of a product comprising: a biofuel component, said biofuel component comprises components (I) and (II) where R is an alkyl chain from a fatty acid derived from triglycerides of an oil or fat of animal or vegetable origin; as a biofuel.